Ojas Shah, MD

Financial relationships

  • Attribution: 
    Self
    Type of financial relationship: 
    Consultant or Advisor (Endourology/Stone Disease)
    Ineligible company: 
    Auris
    Mitigation strategy: 
    Peer review
    Date reviewed: 
    07/07/2023
  • Attribution: 
    Self
    Type of financial relationship: 
    Consultant or Advisor (Endourology/Stone Disease)
    Ineligible company: 
    Ambi
    Mitigation strategy: 
    Peer review
    Date reviewed: 
    07/07/2023
  • Attribution: 
    Self
    Type of financial relationship: 
    Consultant or Advisor (Endourology/Stone Disease)
    Ineligible company: 
    Boston Scientific
    Mitigation strategy: 
    Peer review
    Date reviewed: 
    07/07/2023
  • Attribution: 
    Self
    Type of financial relationship: 
    Meeting Participant or Lecturer (Endourology/Stone Disease)
    Ineligible company: 
    Coloplast
    Mitigation strategy: 
    Peer review
    Date reviewed: 
    07/07/2023
  • Attribution: 
    Self
    Type of financial relationship: 
    Consultant or Advisor (Endourology/Stone Disease)
    Ineligible company: 
    Applaud Medical
    Mitigation strategy: 
    Peer review
    Date reviewed: 
    07/07/2023
  • Attribution: 
    Self
    Type of financial relationship: 
    Meeting Participant or Lecturer (Endourology/Stone Disease)
    Ineligible company: 
    American Urological Association
    Mitigation strategy: 
    Peer review
    Date reviewed: 
    07/07/2023
  • Attribution: 
    Spouse or Partner
    Type of financial relationship: 
    Investment Interest (General Urology)
    Ineligible company: 
    NJ Kidney Stone Center
    Mitigation strategy: 
    Peer review
    Date reviewed: 
    07/07/2023
  • Attribution: 
    Self
    Type of financial relationship: 
    Health Publishing (General Urology)
    Ineligible company: 
    Elsevier
    Mitigation strategy: 
    Peer review
    Date reviewed: 
    07/07/2023
Return to Intern Academy Virtual Didactic Series (2023)